Log In
BCIQ
Print this Print this
 

Tumor necrosis factor (TNF) alpha

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Tumor necrosis factor (TNF) alpha

BCIQ
Print ChartPrint this
0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 1 0 0 1 0 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 2 1 1 0 1 0 0 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 13 4 2 8 1 14 1 2 0 10
Phases of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPivotalPhase IIIPhase IVRegistrationApprovedMarketed
Autoimmune

0

13

4

2

8

1

14

1

2

0

10

Cancer

0

0

1

0

0

0

0

0

0

0

0

Dermatology

0

2

0

0

0

0

1

0

1

0

0

Infectious

0

1

0

0

0

0

0

0

0

0

0

Inflammation

2

1

1

0

1

0

0

0

1

1

1

Neurology

0

2

0

0

0

0

0

0

0

0

0

Ophthalmic

0

1

0

0

1

0

1

0

0

0

0

Pulmonary

0

0

0

0

1

0

0

0

0

0

1

Transplant

0

0

1

0

0

0

0

0

0

0

0




 Products Targeting Tumor necrosis factor (TNF) alpha
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

36

$121,309.8M

$51,952.9M

$744.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today